HEALTHCARE HEROES We are so proud of Dr. Gregory Vidal and Parrish Throckmorton, PT for being nominated as Memphis Business Journal’s healthcare heroes! With 5 nominees in only 5 categories – our West family is elated to have 2 team members recognized for their efforts and relentless pursuit of excellence in healthcare, making them true… Read more »
Posts Tagged: dr. vidal
Identifying Barriers to Health Care for Black Women
Dr. Gregory Vidal is co-leading a groundbreaking study aimed at identifying barriers to health care for Black women in the Mid-South. This initiative, supported by a $1.58 million grant from Gilead Sciences, Inc., is a collaborative effort with Dr. Janeane Anderson from the University of Tennessee Health Science Center’s College of Nursing. This research seeks… Read more »
West Physicians Advocate for Oncology Patients at Capitol Hill
West Cancer Center & Research Institute proudly announces that two of their oncology providers, Dr. Michael Berry, Breast Oncology Surgeon and Dr. Gregory Vidal, Medical Oncologist and Director of Clinical Research recently visited Capitol Hill in Washington, DC. They engaged with lawmakers from across the state and political spectrum to address crucial issues affecting cancer… Read more »
20 West Physicians Named Castle Connolly Top Docs
🏆 20 West physicians have been named Castle Connolly Top Doctors 🏆 Castle Connolly’s Top Docs represent the ✨top 7%✨ of all U.S. practicing physicians! Selected through a rigorous process of peer nominations and thorough vetting by a physician-led research team, these doctors are truly top-notch healthcare providers. Their exceptional clinical care, specialty expertise, and… Read more »
Breast Cancer Disparity Abstract Accepted into SABCS
An abstract created in partnership with Dr. Gregory Vidal and Dr. Andrea Curry of our West family about Addressing Breast Cancer Disparities has been officially accepted by San Antonio Breast Cancer Symposium Alongside Rabble Health and the Urban Health Education & Support Services, this team will present methods used to measurably address social determinants of… Read more »
Looking Towards the Future of HR+/HER2- Breast Cancer
Exciting Advances in Endocrine Therapies for Breast Cancer! 🌟 In a recent OncLive Peer Exchange, our very own Dr. Gregory Vidal shares a panel with Dr. Komal Jhaveri, Dr. Timothy Pluard, Dr. Aditya Bardia, and Dr. VK Gadi to discuss the promising landscape of novel endocrine drugs. Discussion highlights include: – The emergence of selective… Read more »
Best of ASCO – Memphis Conference
This past weekend, Drs. Bradley Somer, Gregory Vidal, and Jason Porter hosted presentations at the Best of ASCO – Memphis Conference! This Post ASCO review showcased abstracts from highly rated presentations and the latest research in oncology education. Our physicians helped lead several discussions including: Dr. Jason Porter: – “Personalizing Treatment for Adult Patients with… Read more »
The Best of ASCO – Memphis
West Medical Oncologists, Dr. Bradley Somer and Dr. Gregory Vidal are two of the presenters for the upcoming Best of ASCO – Memphis Conference. Dr. Vidal will host two sessions: the SEEK Workshop Primer Panel and Diversity in Cancer Care, while Dr. Somer will host a session on GU Cancers. This Post ASCO Review will… Read more »
Standard-of-Care Treatment Approaches for HR+/HER2 Early Breast Cancer ft. Dr. Gregory Vidal
In a recent OncLive Peer Exchange, Dr. Gregory Vidal partnered with a panel of breast oncology experts to discuss the standard-of-care treatment approaches for early-stage HR-positive/HER2-negative breast cancer. Topics include: – Evolution of HER2-negative management – Updates in HR-positive treatment – Importance of genetic testing – Utilization of endocrine therapy – BRCA mutations and… Read more »
Cancer Updates: Free Dinner Series for Regional Providers
CALLING ALL REGIONAL PROVIDERS From now through November, our West family is partnering with Total Health Conferencing to host “Cancer Updates: A Dinner Series for Community Care Teams.” These dinners will consist of educational discussions designed for oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of various cancers. Each tumor-focused program is comprised… Read more »